Corporate

  • March 25, 2026

    Payments Co. Sued Over $3M Liquidity Pool Loan Default

    Payken is facing a Delaware Chancery Court lawsuit alleging the blockchain-based payments company owes roughly $3.2 million after breaching a master credit agreement and failing to repay loans owed to a jointly owned lending vehicle created to provide it with liquid assets.

  • March 25, 2026

    Insurers, Brokers Can't Exit Medicare Advantage Steering Suit

    A Massachusetts federal judge on Wednesday largely rejected a bid by insurers and brokers to toss claims that they colluded in a kickback scheme to steer Medicare Advantage customers to certain companies and to push away disabled individuals.

  • March 25, 2026

    Extreme Networks Must Face Suit Over COVID-Era Demand

    A California federal judge rejected Extreme Networks' bid to dismiss a suit alleging it misled investors about its financial prospects and declining client demand during the COVID-19 pandemic, saying the investors adequately pled that the cloud network equipment company engaged in a scheme to inflate revenues through so-called channel-stuffing.

  • March 25, 2026

    Conn. Regulators Approve $2.4B Eversource Water Co. Sale

    Connecticut's Public Utilities Regulatory Authority on Wednesday approved the transfer of Eversource subsidiary Aquarion Co. to a new public water authority created by the state Legislature, subject to several conditions, while admitting the $2.35 billion price tag placed the deal "on the knife's edge of a public interest finding."

  • March 25, 2026

    DOJ Defends FCA's Qui Tam Constitutionality At 5th Circ.

    The U.S. Department of Justice is urging the Fifth Circuit to reject a healthcare provider's attempt to upend an $8.2 million judgment by arguing the False Claims Act's whistleblower mechanism is unconstitutional, saying every other appeals court has rejected such a claim. 

  • March 25, 2026

    Mom Tying Abbott Formula To Baby's NEC Takes The Stand

    A plaintiff claiming Abbott Laboratories' preterm baby formula contributed to her infant's development of a serious gut condition told an Illinois jury Wednesday that she wouldn't have allowed her baby to consume the formula had she known it increased the risk of the infection, saying her now-teenage daughter still struggles with medical complications as a result.

  • March 25, 2026

    Estate Says OpenAI Suicide Suit Distinct From Murder Suit

    The estate of a man who murdered his mother and died by suicide allegedly because of his use of ChatGPT is urging a California federal court not to dismiss its suit against OpenAI, saying the suit doesn't run parallel to a state court case from the mother's estate.

  • March 25, 2026

    Lender Targets Borrower, Guarantor In $3.8M Default Suit

    A Delaware lender has sued a group of real estate investors and affiliated entities in Delaware Chancery Court, accusing them of defaulting on a $3.8 million mezzanine loan and then diverting collateral to avoid repayment.

  • March 25, 2026

    Turf Company Executive Can't Escape Trade Secrets Suit

    An executive must face a turf manufacturer's suit claiming he took confidential information with him when he jumped ship for a rival company, a Georgia federal judge ruled, but said a lack of plausible misconduct allegations meant that rival should be dismissed from the case. 

  • March 25, 2026

    Ashurst Adds 4 Ex-Bracewell Partners To Finance Practice

    Ashurst LLP has announced the addition of a four-partner team in New York to expand its finance and restructuring capacities ahead of a proposed merger with Perkins Coie LLP.

  • March 25, 2026

    Judge Trims SEC Fraud Case Over Cancer Drug Claims

    A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques" about a cancer drug.

  • March 25, 2026

    Insurer Need Not Cover Parkinson's Drug Antitrust Dispute

    An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute does not involve "securities claims" covered under the insurer's policy.

  • March 25, 2026

    Del. Chancellor Pauses Tesla Suit As Musk Cites LinkedIn Post

    The Delaware Chancery Court has paused a high-profile Tesla stockholder case following a recusal bid from Elon Musk and Tesla Inc. after a judge's LinkedIn account appeared to react to a post celebrating a recent California jury verdict against Musk, including language praising efforts to stand up to "the richest man in the world."

  • March 25, 2026

    Utah Expands Unrelated Biz Income Definition For Corp. Tax

    Utah will expand its definition of corporate income to include income allocated to the state under a bill signed by the state's governor.

  • March 25, 2026

    Jury Doubles Damages Against Meta, Google In LA Bellwether

    A California state jury that found Meta and Google liable Wednesday for harming the mental health of a woman who says she became addicted to their social media platforms as a child delivered a second blow later in the day, awarding $3 million in punitive damages on top of a $3 million compensatory award.

  • April 01, 2026

    White & Case Expands In Brussels With Amazon Hire

    White & Case LLP has recruited a senior in-house lawyer at Amazon for its office in Brussels, the law firm's latest technology-focused hire globally.

  • March 25, 2026

    High Court Reverses Music Piracy Liability Ruling Against Cox

    The U.S. Supreme Court on Wednesday said the Fourth Circuit incorrectly affirmed a jury verdict that found Cox Communications liable for its customers' music piracy, concluding there is a legal distinction between mere knowledge of infringement and intent to promote it.

  • March 24, 2026

    Pentagon 'Punishing' Anthropic Would Be Illegal, Judge Says

    A California federal judge considering Anthropic's request to block the U.S. Department of Defense from labeling it a supply chain national security risk said Tuesday that it looks like the government is "punishing" Anthropic for bringing public attention to their contract fight, a move that would violate the First Amendment.

  • March 24, 2026

    Meta Tackles Borrowed Underwear Analogy In Privacy Suit

    A California federal judge mulling Meta's argument that its users' consent bars a proposed privacy class action pressed Meta's lawyers Tuesday on whether social expectations affect the bounds of that consent, observing that if she gave a friend permission to borrow her clothes, "I don't expect her to borrow my underwear."

  • March 24, 2026

    Iowa Asks 5th Circ. To Ax 'Uncertain' Schwab Antitrust Deal

    Iowa's attorney general Monday pressed the Fifth Circuit to reject investors' deal with The Charles Schwab Corp. in an antitrust suit over its merger with TD Ameritrade, arguing it offers only uncertain and hypothetical relief to class members while giving named plaintiffs and class counsel a "windfall."

  • March 24, 2026

    AI Tools May 'Disrobe' Meta Of Section 230 Shield, Judge Says

    A California federal judge trimmed Tuesday a proposed class action alleging Meta Platforms Inc. knowingly participated in a Chinese pump-and-dump scheme advertised on social media, but found there's a factual dispute over whether Meta's AI tools materially contributed to the "facially ridiculous" ads.

  • March 24, 2026

    FINRA CEO Highlights New Clearinghouse For Cyber Threats

    Robert Cook, CEO of the Financial Industry Regulatory Authority, said Tuesday that it will soon be rolling out a clearinghouse for firms to report cybersecurity threats and to promote information sharing across the industry.

  • March 24, 2026

    Drug Co. Atara Hit With Investor Suit Over FDA Denial

    Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it unlikely the U.S. Food and Drug Administration would approve its new drug application.

  • March 24, 2026

    Delaware Court Tosses Allied Gaming Suit, Awards $5.9M Fees

    The Delaware Chancery Court on Tuesday dismissed a stockholder challenge to a disputed share issuance at Allied Gaming & Entertainment Inc. as moot, while ordering the company to pay nearly $5.94 million in attorney fees and expenses after finding that the litigation prompted the company to reverse course.

  • March 24, 2026

    Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP

    Sarepta Therapeutics Inc. wants the full Federal Circuit to rethink a decision reviving a University of Pennsylvania gene therapy patent, saying a panel got its analysis of patent eligibility wrong.

Expert Analysis

  • Navigating Privilege Law Patchwork In Dual-Purpose Comms

    Author Photo

    Three years after the U.S. Supreme Court declined to resolve a circuit split in In re: Grand Jury, federal courts remain split as to when attorney-client privilege applies to dual-purpose legal and business communications, and understanding the fragmented landscape is essential for managing risks, say attorneys at Covington.

  • Key Changes In World Bank's New Compliance Updates

    Author Photo

    Recent updates to integrity guidelines for companies that bid and work on World Bank-financed projects are sufficiently extensive and unique that covered businesses must take proactive steps to map the changes against their existing compliance programs or risk severe business consequences, say attorneys at Steptoe.

  • Decoding The SEC's Plans To Revitalize The US IPO Market

    Author Photo

    Chairman Paul Atkins' recent speech showcased the U.S. Securities and Exchange Commission's plans to ease certain disclosure burdens, rein in politicized shareholder voting and mitigate litigation risk, which could encourage more U.S. companies to seek public listings stateside and make U.S. stock exchanges more competitive for foreign companies, say attorneys at Baker McKenzie.

  • Banking Regulation Themes To Anticipate In 2026

    Author Photo

    The banking enforcement and rulemaking agenda for this year is likely to reflect a mix of targeted reform, deregulatory recalibration and new priorities aligned with supervisory modernization, says Kim Prior at King & Spalding.

  • 2 OFAC Sanctions Actions Highlight PE Compliance Risk

    Author Photo

    Recent Office of Foreign Assets Control enforcement actions against two private equity firms for facilitating sanctioned persons' access to the U.S. financial system underscore the need for nonbank financial institutions' compliance programs to consider the sanctions risk of their investors, including indirect dealings with blocked persons, say attorneys at Paul Weiss.

  • Series

    Calif. Banking Brief: All The Notable Legal Updates In Q4

    Author Photo

    The regulatory and litigation developments for California financial institutions in the fourth quarter of 2025 were incremental but consequential, with the Department of Financial Protection & Innovation relying on public enforcement actions to articulate expectations, and lawmakers and privacy regulators playing a role as well, says Stephen Britt at Stinson.

  • Series

    Fly-Fishing Makes Me A Better Lawyer

    Author Photo

    Much like skilled attorneys, the best anglers prize preparation, presentation and patience while respecting their adversaries — both human and trout, says Rob Braverman at Braverman Greenspun.

  • 4 Ways GCs Can Manage Growing Service Of Process Volume

    Author Photo

    As automation and arbitration increase the volume of legal filings, in-house counsel must build scalable service of process systems that strengthen corporate governance and manage risk in real time, says Paul Mathews at Corporation Service Co.

  • Series

    NY Banking Brief: All The Notable Legal Updates In Q4

    Author Photo

    In the fourth quarter of last year, New York state enacted several developments that affect financial services regulation and business, cementing upcoming compliance obligations including cybersecurity best practices and retail stores' cash management, says Chris Bonner at Barclay Damon.

  • SDNY Atty Signals Return To Private Fund Valuation Scrutiny

    Author Photo

    Recent remarks by the U.S. Attorney for the Southern District of New York — hinting that regulators are renewing their focus on private fund advisers who overvalue portfolio assets to drive up investor fees — should prompt firms to review their valuation methodologies and address potential conflicts of interest now, say attorneys at Debevoise.

  • IP Appellate Decisions Show 4 Shifts In 2025

    Author Photo

    In 2025, intellectual property decisions issued by the Ninth, D.C., and Federal Circuits trended toward tightening doctrinal boundaries, whether to account for technological developments in existing legal regimes, or to refine areas with some ambiguity, says Nate Sabri at Perkins Coie.

  • Series

    The Law Firm Merger Diaries: Forming Measurable Ties

    Author Photo

    Relationship-building should begin as early as possible in a law firm merger, as intentional pathways to bringing people together drive collaboration, positive client response, engagements and growth, says Amie Colby at Troutman.

  • Del. Dispatch: What Tesla Decision Means For Exec Comp

    Author Photo

    The recent Delaware Supreme Court decision granting Tesla CEO Elon Musk his full pay, now valued at $139 billion, following a yearslong battle appears to reject the view that supersized compensation may be inherently unfair to a corporation and its shareholders, say attorneys at Fried Frank.

  • Wis. Sanctions Order May Shake Up Securities Class Actions

    Author Photo

    A Wisconsin federal court’s recent decision to impose sanctions on a plaintiffs law firm for filing a frivolous Private Securities Litigation Reform Act complaint in Toft v. Harbor Diversified may cause both plaintiffs and defendants law firms to reconsider certain customary practices in securities class actions, says Jonathan Richman at Brown Rudnick.

  • 5 E-Discovery Predictions For 2026 And Beyond

    Author Photo

    2026 will likely be shaped by issues ranging from artificial intelligence regulatory turbulence to potential evidence rule changes, and e-discovery professionals will need to understand how to effectively guide the responsible and defensible adoption of emerging tools, while also ensuring effective safeguards, say attorneys at Littler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.